Lantern Pharma LTRN

$ 2.92 -0.85%

Quarterly report 2024-Q3
added 11-07-2024

Lantern Pharma Financial Statements 2011-2024 | LTRN

Annual Financial Statements Lantern Pharma

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	108 M	50.7 M	67.2 M	93.5 M	-	-	-	-	-	-	-	-	-
Shares	10.8 M	10.9 M	10.9 M	6.22 M	-	-	-	-	-	-	-	-	-
Historical Prices	9.96	4.67	6.16	17.8	-	-	-	-	-	-	-	-	-
Net Income	-16 M	-14.3 M	-12.4 M	-5.91 M	-2.43 M	-1.73 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-17.9 M	-14.4 M	-12.6 M	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.15 M	-31.5 K	161 K	-	-	-	-	-	-	-	-	-	-
EBITDA	-17.9 M	-14.4 M	-12.6 M	-5.9 M	-2.43 M	-1.73 M	-	-	-	-	-	-	-
Operating Expenses	17.9 M	14.4 M	12.6 M	5.91 M	2.43 M	1.73 M	-	-	-	-	-	-	-
General and Administrative Expenses	5.98 M	5.83 M	105 K	3.66 M	1.48 M	1.15 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Lantern Pharma

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	10.8 M	10.8 M	10.7 M	10.9 M	10.9 M	10.9 M	10.9 M	10.8 M	10.8 M	10.9 M	11.1 M	11.2 M	11.2 M	10.1 M	6.22 M	6.22 M	2.72 M	2.02 M	1.98 M	1.98 M	1.98 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-4.51 M	-4.96 M	-	-3.16 M	-4.75 M	-3.87 M	-	-2.26 M	-4.49 M	-4.12 M	-	-4.05 M	-2.32 M	-2.45 M	-	-1.7 M	-833 K	-477 K	-	-670 K	-629 K	-454 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-5.18 M	-5.41 M	-	-3.52 M	-5.19 M	-4.29 M	-	-2.15 M	-4.39 M	-4.07 M	-	-4.15 M	-2.48 M	-	-	-1.7 M	-833 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	483 K	260 K	-	116 K	326 K	285 K	-	-172 K	-153 K	-77.8 K	-	17.7 K	115 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-4.28 M	-	-2.14 M	-4.39 M	-4.06 M	-	-4.14 M	-2.48 M	1.34 K	-	-1.7 M	-832 K	536	-	1.09 K	629	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	5.18 M	5.41 M	-	3.52 M	5.19 M	4.29 M	-	2.15 M	4.39 M	4.07 M	-	4.15 M	2.48 M	2.45 M	-	1.7 M	833 K	477 K	-	670 K	629 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.46 M	1.52 M	-	1.31 M	1.63 M	42 K	-	1.44 M	1.41 M	39 K	-	38 K	27 K	2 K	-	1 K	12 K	340 K	-	441 K	268 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency